| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Departments of 1 Oncological Sciences and 2 Medicinal Chemistry and the 3 Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
Requests for reprints: David A. Jones, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112. Phone: 801-585-6107; Fax: 801-585-0900; E-mail: david.jones{at}hci.utah.edu.
Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene seem to underlie the initiation of many colorectal carcinomas. Loss of APC function results in accumulation of ß-catenin and activation of ß-catenin/TCFdependent transcription. Recent studies have implicated APC in controlling retinoic acid biosynthesis during normal intestinal development through a WNT-independent mechanism. Paradoxically, however, previous studies found that dietary supplementation of ApcMIN mice with retinoic acid failed to abrogate adenoma formation. While investigating the above finding, we found that expression of CYP26A1, a major retinoic acid catabolic enzyme, was up-regulated in ApcMIN mouse adenomas, human FAP adenomas, human sporadic colon carcinomas, and in the intestine of apcmcr mutant zebrafish embryos. Mechanistically, cyp26a1 induction following apc mutation is dependent on WNT signaling as antisense morpholino knockdown of tcf4 or injection of a dnLEF construct into apcmcr mutant zebrafish suppressed expression of cyp26a1 along with known WNT target genes. In addition, injection of stabilized ß-catenin or dnGSK3ß into wild-type embryos induced cyp26a1 expression. Genetic knockdown or pharmacologic inhibition of cyp26a1 in apcmcr mutant zebrafish embryos rescued gut differentiation defects such as expression of intestinal fatty acidbinding protein and pancreatic trypsin. These findings support a novel role for APC in balancing retinoic acid biosynthesis and catabolism through WNT-independent and WNT-dependent mechanisms. (Cancer Res 2006; 66(15): 7571-7)
This article has been cited by other articles:
![]() |
Y.-J. Kim, S. Y. Yoon, J.-T. Kim, E. Y. Song, H. G. Lee, H. J. Son, S. Y. Kim, D. Cho, I. Choi, J. H. Kim, et al. NDRG2 expression decreases with tumor stages and regulates TCF/{beta}-catenin signaling in human colon carcinoma Carcinogenesis, April 1, 2009; 30(4): 598 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Laue, M. Janicke, N. Plaster, C. Sonntag, and M. Hammerschmidt Restriction of retinoic acid activity by Cyp26b1 is required for proper timing and patterning of osteogenesis during zebrafish development Development, November 15, 2008; 135(22): 3775 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates Cancer Res., September 15, 2008; 68(18): 7394 - 7402. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Goessling, T. E. North, and L. I. Zon New Waves of Discovery: Modeling Cancer in Zebrafish J. Clin. Oncol., June 10, 2007; 25(17): 2473 - 2479. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |